Abstract:Programmed cell death (PCD) is an essential part of organismal development and plays fundamental roles in host defense against pathogens and the maintenance of homeostasis. However, excess activation of PCD pathways has proven to be detrimental and can drive disease. Additionally, resistance to PCD can also contribute to disease development. Modulation of PCD, therefore, has great therapeutic potential in a wide range of diseases, including infectious, neurodegenerative, autoinflammatory, and metabolic diseases and cancer. Nevertheless, manipulation of cell death and inflammation for therapeutic intervention is a delicate process, highly specific to the context of the disease of interest, making the selection of the appropriate target molecule crucially important. Several PCD pathways are associated with innate immunity, including pyroptosis, apoptosis, necroptosis, and PANoptosis, which is defined as an inflammatory PCD pathway with key features of pyroptosis, apoptosis, and/or necroptosis that cannot be accounted for by any of these three PCD pathways alone. All of these PCD pathways are regulated by upstream sensors and signaling cascades that assemble multimeric complexes to serve as activation platforms for downstream molecules; these sensors and signaling molecules provide attractive target points for therapeutic intervention. Here, we discuss the molecular mechanisms of innate immune-mediated cell death in health and disease, with a particular focus on the molecules putatively involved in the formation of the PANoptosome and the induction of inflammatory cell death. Further, we discuss the implications and feasibility of targeting these molecules to improve disease outcomes, as well as current clinical approaches.

New perspective for pathomechanism and clinical applications of animal toxins: Programmed cell death

Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment

Programmed cell death in spinal cord injury pathogenesis and therapy

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways

Research progress on morphology and mechanism of programmed cell death

Programming inflammatory cell death for therapy

Dissecting Cell Death with Proteomic Scalpels

Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases

PANoptosis: Mechanisms, biology, and role in disease

PANoptosis: Novel insight into regulated cell death and its potential role in cardiovascular diseases (Review)

Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives

PANoptosis: Emerging mechanisms and disease implications

Programmed cell death in tumor immunity: mechanistic insights and clinical implications

The Application of Genome-wide CRISPR-Cas9 Screens to Dissect the Molecular Mechanisms of Toxins

Research Advances of the Relationship Between Caspase8 in Programmed Cell Death and Disease

Emerging connectivity of programmed cell death pathways and its physiological implications

Progress in Programmed Cell Death Pathways

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Involvement of Programmed Cell Death in Neurotoxicity of Metallic Nanoparticles: Recent Advances and Future Perspectives